Research progress in methods for detecting neutralizing antibodies against SARS-CoV-2
C Chen, J Liang, H Hu, X Li, L Wang, Z Wang - Analytical Biochemistry, 2023 - Elsevier
The emergence of SARS-CoV-2 has seriously affected the lives of people worldwide.
Clarifying the attenuation rule of SARS-CoV-2 neutralizing antibody (NAb) in vivo is the key …
Clarifying the attenuation rule of SARS-CoV-2 neutralizing antibody (NAb) in vivo is the key …
Evaluation of Monkeypox-and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection
A Manenti, N Solfanelli, P Cantaloni… - Frontiers in Public …, 2023 - frontiersin.org
Introduction In early to mid-2022, an unexpected outbreak of Monkeypox virus infections
occurred outside the African endemic regions. Vaccines originally developed in the past to …
occurred outside the African endemic regions. Vaccines originally developed in the past to …
Antibody Avidity and Neutralizing Response against SARS‐CoV‐2 Omicron Variant after Infection or Vaccination
Background. The recently emerged SARS‐CoV‐2 Omicron variant exhibits several
mutations on the spike protein, enabling it to escape the immunity elicited by natural …
mutations on the spike protein, enabling it to escape the immunity elicited by natural …
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
DA Rothen, PS Krenger, A Nonic, I Balke, ACS Vogt… - Allergy, 2022 - Wiley Online Library
Background The highly contagious SARS‐CoV‐2 is mainly transmitted by respiratory
droplets and aerosols. Consequently, people are required to wear masks and maintain a …
droplets and aerosols. Consequently, people are required to wear masks and maintain a …
Cellular and humoral immune responses and breakthrough infections after two doses of BNT162b vaccine in healthcare workers (HW) 180 days after the second …
Background Immunity and clinical protection induced by mRNA vaccines against SARS-CoV-
2 have been shown to decline overtime. To gather information on the immunity profile …
2 have been shown to decline overtime. To gather information on the immunity profile …
[HTML][HTML] Efficacy of mucosal vaccination using a protozoan parasite as a vehicle for antigen delivery: IgG and neutralizing response after rectal administration of …
Mucosal vaccination is regarded as a promising alternative to classical, intramuscular
vaccine delivery. However, only a limited number of vaccines have been licensed for …
vaccine delivery. However, only a limited number of vaccines have been licensed for …
Establishment and validation of a high‐throughput micro‐neutralization assay for respiratory syncytial virus (subtypes A and B)
C Bonifazi, CM Trombetta, I Barneschi… - Journal of Medical …, 2023 - Wiley Online Library
The validation of a bioanalytical method allows us to determine its validity for a designated
purpose and to guarantee the reliability of its analytical results. The virus neutralization …
purpose and to guarantee the reliability of its analytical results. The virus neutralization …
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses
L Benincasa, E Molesti, A Manenti… - Letters in Drug …, 2023 - ingentaconnect.com
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a positive-
sense, single stranded RNA virus, responsible for the pandemic outbreak called COVID-19 …
sense, single stranded RNA virus, responsible for the pandemic outbreak called COVID-19 …
Intranasal administration of a VLP-based vaccine against COVID-19 induces neutralizing antibodies against SARS-CoV-2 and variants of concerns
DA Rothen, PS Krenger, A Nonic, I Balke, ACS Vogt… - bioRxiv, 2021 - biorxiv.org
Background The highly contagious SARS-CoV-2 is mainly transmitted by respiratory
droplets and aerosols. Consequently, people are required to wear masks and maintain a …
droplets and aerosols. Consequently, people are required to wear masks and maintain a …
[PDF][PDF] Research Article Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
Background. The recently emerged SARS-CoV-2 Omicron variant exhibits several mutations
on the spike protein, enabling it to escape the immunity elicited by natural infection or …
on the spike protein, enabling it to escape the immunity elicited by natural infection or …